Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 524

1.

Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial.

Lenferink A, van der Palen J, van der Valk PDLPM, Cafarella P, van Veen A, Quinn S, Groothuis-Oudshoorn CGM, Burt MG, Young M, Frith PA, Effing TW.

Eur Respir J. 2019 Aug 14. pii: 1802134. doi: 10.1183/13993003.02134-2018. [Epub ahead of print]

PMID:
31413163
2.

[Paraneoplastic syndromes].

Opstelten W, van der Valk PGM, Smulders YM.

Ned Tijdschr Geneeskd. 2019 Jun 17;163. pii: D4143. Dutch.

PMID:
31283129
3.

Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient.

van Rossum JA, Peters MAD, van der Valk P, de Jong BA.

Mult Scler Relat Disord. 2019 Jun 8;34:38-40. doi: 10.1016/j.msard.2019.06.006. [Epub ahead of print] No abstract available.

PMID:
31228714
4.

Biochemically silent sympathetic Paraganglioma, Pheochromocytoma or Metastatic Disease in SDHD mutation carriers.

Dreijerink KMA, Rijken JA, Compaijen CJAC, Timmers HJLM, van der Horst-Schrivers ANA, van Leeuwaarde RS, Sytze van Dam P, Leemans CR, van Dam EWCM, Dickhoff C, Dommering CJ, de Graaf P, Zwezerijnen GJCB, van der Valk P, Menke-Van der Houven van Oordt CW, Hensen EF, Corssmit EPM, Eekhoff EMW.

J Clin Endocrinol Metab. 2019 Jun 13. pii: jc.2019-00202. doi: 10.1210/jc.2019-00202. [Epub ahead of print]

PMID:
31194241
5.

[Specialization versus generalization in pathology].

van der Valk P.

Ned Tijdschr Geneeskd. 2019 May 3;163. pii: D3585. Dutch.

PMID:
31120215
6.

CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions.

Prins HJ, Duijkers R, van der Valk P, Schoorl M, Daniels JMA, van der Werf TS, Boersma WG.

Eur Respir J. 2019 May 23;53(5). pii: 1802014. doi: 10.1183/13993003.02014-2018. Print 2019 May.

PMID:
30880285
7.

Poststreptococcal Myalgia and Myositis.

Bomers MK, van Doorn-Schepens MLM, van der Valk P, Peters EJG.

Ann Intern Med. 2019 Jun 18;170(12):901-904. doi: 10.7326/L18-0589. Epub 2019 Jan 22. No abstract available.

PMID:
30665234
8.

[Overtreatment of premalignant and malignant skin lesions.]

van der Valk PGM.

Ned Tijdschr Geneeskd. 2018 Dec 5;162. pii: D3542. Dutch.

PMID:
30570951
9.

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication.

Koehorst-Ter Huurne K, Brusse-Keizer M, van der Valk P, Movig K, van der Palen J, Bode C.

Patient Prefer Adherence. 2018 Sep 12;12:1777-1783. doi: 10.2147/PPA.S167002. eCollection 2018.

10.

Continuous infusion of extended half-life factor VIII (efmoroctocog alpha) for surgery in severe haemophilia A.

Kremer Hovinga ICL, Schutgens REG, van der Valk PR, van Vulpen LFD, Mauser-Bunschoten EP, Fischer K.

Haemophilia. 2018 Jul;24(4):e280-e283. doi: 10.1111/hae.13557. Epub 2018 Jul 25. No abstract available.

PMID:
30044044
11.

Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis.

Gorter RP, Nutma E, Jahrei MC, de Jonge JC, Quinlan RA, van der Valk P, van Noort JM, Baron W, Amor S.

Clin Exp Immunol. 2018 Nov;194(2):137-152. doi: 10.1111/cei.13186. Epub 2018 Sep 19.

12.

MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles.

Jansen RW, de Jong MC, Kooi IE, Sirin S, Göricke S, Brisse HJ, Maeder P, Galluzzi P, van der Valk P, Cloos J, Eekhout I, Castelijns JA, Moll AC, Dorsman JC, de Graaf P.

Radiology. 2018 Aug;288(2):506-515. doi: 10.1148/radiol.2018172000. Epub 2018 May 1.

PMID:
29714679
13.
14.

Inflammation in CNS neurodegenerative diseases.

Stephenson J, Nutma E, van der Valk P, Amor S.

Immunology. 2018 Jun;154(2):204-219. doi: 10.1111/imm.12922. Epub 2018 Apr 17. Review.

15.

Stable-State Midrange Proadrenomedullin Is Associated With Severe Exacerbations in COPD.

Citgez E, Zuur-Telgen M, van der Palen J, van der Valk P, Stolz D, Brusse-Keizer M.

Chest. 2018 Jul;154(1):51-57. doi: 10.1016/j.chest.2018.02.006. Epub 2018 Feb 21.

PMID:
29475034
16.

9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology.

de Jong MC, de Graaf P, Pouwels PJW, Beenakker JW, Jansen RW, Geurts JJG, Moll AC, Castelijns JA, van der Valk P, van der Weerd L.

J Magn Reson Imaging. 2018 Jun;47(6):1487-1497. doi: 10.1002/jmri.25913. Epub 2017 Nov 28.

PMID:
29193569
17.

Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD.

Prins HJ, Duijkers R, Lutter R, Daniels JM, van der Valk P, Schoorl M, Kerstjens HA, van der Werf TS, Boersma WG.

Respir Med. 2017 Oct;131:118-124. doi: 10.1016/j.rmed.2017.07.064. Epub 2017 Aug 1.

PMID:
28947018
18.

Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.

Lenferink A, Brusse-Keizer M, van der Valk PD, Frith PA, Zwerink M, Monninkhof EM, van der Palen J, Effing TW.

Cochrane Database Syst Rev. 2017 Aug 4;8:CD011682. doi: 10.1002/14651858.CD011682.pub2. Review.

19.

Neurofilament light as an immune target for pathogenic antibodies.

Puentes F, van der Star BJ, Boomkamp SD, Kipp M, Boon L, Bosca I, Raffel J, Gnanapavan S, van der Valk P, Stephenson J, Barnett SC, Baker D, Amor S.

Immunology. 2017 Dec;152(4):580-588. doi: 10.1111/imm.12797. Epub 2017 Aug 11.

20.

Analysing Tuberculosis Cases Among Healthcare Workers to Inform Infection Control Policy and Practices.

de Vries G, van Hunen R, Meerstadt-Rombach FS, van der Valk PDLPM, Vermue M, Keizer ST.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):976-982. doi: 10.1017/ice.2017.100. Epub 2017 Jun 8.

PMID:
28592346
21.

Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.

Strijbis EMM, Kooi EJ, van der Valk P, Geurts JJG.

J Neuropathol Exp Neurol. 2017 May 1;76(5):390-401. doi: 10.1093/jnen/nlx023.

PMID:
28521040
22.

The Mozart study: a relation between dynamic hyperinflation and physical activity in patients with chronic obstructive pulmonary disease?

van Leuteren RW, Dijkhuis S, de Jongh FHC, van der Valk PDLPM, Tabak M, Brusse-Keizer MGJ.

Clin Physiol Funct Imaging. 2018 May;38(3):409-415. doi: 10.1111/cpf.12430. Epub 2017 Apr 12.

PMID:
28402088
23.

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.

van der Palen J, Thomas M, Chrystyn H, Sharma RK, van der Valk PD, Goosens M, Wilkinson T, Stonham C, Chauhan AJ, Imber V, Zhu CQ, Svedsater H, Barnes NC.

NPJ Prim Care Respir Med. 2017 Mar 23;27:17001. doi: 10.1038/npjpcrm.2017.1. No abstract available.

24.

Identification of highly connected hub genes in the protective response program of human macrophages and microglia activated by alpha B-crystallin.

Holtman IR, Bsibsi M, Gerritsen WH, Boddeke HW, Eggen BJ, van der Valk P, Kipp M, van Noort JM, Amor S.

Glia. 2017 Mar;65(3):460-473. doi: 10.1002/glia.23104. Epub 2017 Jan 7.

PMID:
28063173
25.

Symptomatic unilateral sacroiliitis as a first presenting feature of IgG4-related disease with successful response to treatment after 1 year of follow-up article.

Jamnitski A, van Hall O, de Vries N, van der Valk P, Lems WF, van der Horst-Bruinsma IE.

Rheumatology (Oxford). 2017 Apr 1;56(4):670-671. doi: 10.1093/rheumatology/kew481. No abstract available.

PMID:
28039416
26.

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.

van der Palen J, Thomas M, Chrystyn H, Sharma RK, van der Valk PD, Goosens M, Wilkinson T, Stonham C, Chauhan AJ, Imber V, Zhu CQ, Svedsater H, Barnes NC.

NPJ Prim Care Respir Med. 2016 Nov 24;26:16079. doi: 10.1038/npjpcrm.2016.79. Erratum in: NPJ Prim Care Respir Med. 2017 Mar 23;27:17001.

27.

The association of haemophilic arthropathy with Health-Related Quality of Life: a post hoc analysis.

Fischer K, de Kleijn P, Negrier C, Mauser-Bunschoten EP, van der Valk PR, van Galen KP, Willemze A, Schutgens R.

Haemophilia. 2016 Nov;22(6):833-840. doi: 10.1111/hae.13120. Epub 2016 Oct 26.

PMID:
27785891
28.

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.

Koehorst-Ter Huurne K, Kort S, van der Palen J, van Beurden WJ, Movig KL, van der Valk P, Brusse-Keizer M.

Int J Chron Obstruct Pulmon Dis. 2016 Jul 26;11:1679-88. doi: 10.2147/COPD.S107303. eCollection 2016.

29.

Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.

Creemers SG, van Koetsveld PM, van Kemenade FJ, Papathomas TG, Franssen GJ, Dogan F, Eekhoff EM, van der Valk P, de Herder WW, Janssen JA, Feelders RA, Hofland LJ.

Endocr Relat Cancer. 2016 Sep;23(9):727-37. doi: 10.1530/ERC-16-0266.

PMID:
27535174
30.

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study.

Citgez E, van der Palen J, Koehorst-Ter Huurne K, Movig K, van der Valk P, Brusse-Keizer M.

BMJ Open Respir Res. 2016 Jun 17;3(1):e000142. doi: 10.1136/bmjresp-2016-000142. eCollection 2016.

31.

Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice.

Peferoen LA, Breur M, van de Berg S, Peferoen-Baert R, Boddeke EH, van der Valk P, Pryce G, van Noort JM, Baker D, Amor S.

Immunology. 2016 Oct;149(2):146-56. doi: 10.1111/imm.12644. Epub 2016 Aug 9.

32.

Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.

Burm SM, Peferoen LA, Zuiderwijk-Sick EA, Haanstra KG, 't Hart BA, van der Valk P, Amor S, Bauer J, Bajramovic JJ.

J Neuroinflammation. 2016 Jun 6;13(1):138. doi: 10.1186/s12974-016-0605-8.

33.

A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.

Kooi IE, Mol BM, Massink MP, de Jong MC, de Graaf P, van der Valk P, Meijers-Heijboer H, Kaspers GJ, Moll AC, Te Riele H, Cloos J, Dorsman JC.

PLoS One. 2016 Apr 26;11(4):e0153323. doi: 10.1371/journal.pone.0153323. eCollection 2016.

34.

Definition of a COPD self-management intervention: International Expert Group consensus.

Effing TW, Vercoulen JH, Bourbeau J, Trappenburg J, Lenferink A, Cafarella P, Coultas D, Meek P, van der Valk P, Bischoff EW, Bucknall C, Dewan NA, Early F, Fan V, Frith P, Janssen DJ, Mitchell K, Morgan M, Nici L, Patel I, Walters H, Rice KL, Singh S, Zuwallack R, Benzo R, Goldstein R, Partridge MR, van der Palen J.

Eur Respir J. 2016 Jul;48(1):46-54. doi: 10.1183/13993003.00025-2016. Epub 2016 Apr 13.

35.

Safety and long-term effects of renal denervation: Rationale and design of the Dutch registry.

Sanders MF, Blankestijn PJ, Voskuil M, Spiering W, Vonken EJ, Rotmans JI, van der Hoeven BL, Daemen J, van den Meiracker AH, Kroon AA, de Haan MW, Das M, Bax M, van der Meer IM, van Overhagen H, van den Born BJ, van Brussel PM, van der Valk PH, Smak Gregoor PJ, Meuwissen M, Gomes ME, Oude Ophuis T, Troe E, Tonino WA, Konings CJ, de Vries PA, van Balen A, Heeg JE, Smit JJ, Elvan A, Steggerda R, Niamut SM, Peels JO, de Swart JB, Wardeh AJ, Groeneveld JH, van der Linden E, Hemmelder MH, Folkeringa R, Stoel MG, Kant GD, Herrman JP, van Wissen S, Deinum J, Westra SW, Aengevaeren WR, Parlevliet KJ, Schramm A, Jessurun GA, Rensing BJ, Winkens MH, Wierema TK, Santegoets E, Lipsic E, Houwerzijl E, Kater M, Allaart CP, Nap A, Bots ML.

Neth J Med. 2016 Jan;74(1):5-15.

37.

Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD (STONAC 1 and STONAC 2).

Nijdam LC, Assink MD, Kuijvenhoven JC, de Saegher ME, van der Valk PD, van der Palen J, Brusse-Keizer MG, Movig KL.

COPD. 2016 Aug;13(4):448-54. doi: 10.3109/15412555.2015.1107893. Epub 2016 Jan 8.

PMID:
26744171
38.

Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.

Peferoen LA, Gerritsen WH, Breur M, Ummenthum KM, Peferoen-Baert RM, van der Valk P, van Noort JM, Amor S.

Acta Neuropathol Commun. 2015 Dec 22;3:87. doi: 10.1186/s40478-015-0267-2.

39.

Diagnostic Accuracy of Intraocular Tumor Size Measured with MR Imaging in the Prediction of Postlaminar Optic Nerve Invasion and Massive Choroidal Invasion of Retinoblastoma.

De Jong MC, van der Meer FJ, Göricke SL, Brisse HJ, Galluzzi P, Maeder P, Sirin S, De Francesco S, Sastre-Garau X, Metz KA, Cerase A, Noij DP, van der Valk P, Moll AC, Castelijns JA, de Graaf P; European Retinoblastoma Imaging Collaboration.

Radiology. 2016 Jun;279(3):817-26. doi: 10.1148/radiol.2015151213. Epub 2015 Dec 19.

PMID:
26690907
40.

The influence of type of inhalation device on adherence of COPD patients to inhaled medication.

Koehorst-ter Huurne K, Movig K, van der Valk P, van der Palen J, Brusse-Keizer M.

Expert Opin Drug Deliv. 2016;13(4):469-75. doi: 10.1517/17425247.2016.1130695. Epub 2016 Jan 4.

PMID:
26666841
41.

(Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT.

Zwerink M, Kerstjens HA, van der Palen J, van der Valk P, Brusse-Keizer M, Zielhuis G, Effing T.

Respirology. 2016 Apr;21(3):497-503. doi: 10.1111/resp.12697. Epub 2015 Dec 9.

42.

Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.

Nijland PG, Molenaar RJ, van der Pol SM, van der Valk P, van Noorden CJ, de Vries HE, van Horssen J.

Acta Neuropathol Commun. 2015 Dec 4;3:79. doi: 10.1186/s40478-015-0261-8.

43.

Cost-Effectiveness of a Community-Based Exercise Programme in COPD Self-Management.

Zwerink M, Effing T, Kerstjens HA, van der Valk P, Brusse-Keizer M, Zielhuis G, van der Palen J.

COPD. 2016;13(2):214-23. doi: 10.3109/15412555.2015.1074171. Epub 2015 Dec 1.

PMID:
26623496
44.

Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.

Ummenthum K, Peferoen LA, Finardi A, Baker D, Pryce G, Mantovani A, Bsibsi M, Bottazzi B, Peferoen-Baert R, van der Valk P, Garlanda C, Kipp M, Furlan R, van Noort JM, Amor S.

Eur J Immunol. 2016 Mar;46(3):701-11. doi: 10.1002/eji.201545950. Epub 2015 Dec 14.

45.

Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.

Große-Veldmann R, Becker B, Amor S, van der Valk P, Beyer C, Kipp M.

Mol Neurobiol. 2016 Sep;53(7):4905-17. doi: 10.1007/s12035-015-9420-y. Epub 2015 Sep 12.

PMID:
26363796
46.

Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.

Kooi IE, Mol BM, Moll AC, van der Valk P, de Jong MC, de Graaf P, van Mil SE, Schouten-van Meeteren AY, Meijers-Heijboer H, Kaspers GL, Te Riele H, Cloos J, Dorsman JC.

EBioMedicine. 2015 Jul 8;2(7):660-70. doi: 10.1016/j.ebiom.2015.06.022. eCollection 2015 Jul.

47.

Pathological differences between white and grey matter multiple sclerosis lesions.

Prins M, Schul E, Geurts J, van der Valk P, Drukarch B, van Dam AM.

Ann N Y Acad Sci. 2015 Sep;1351:99-113. doi: 10.1111/nyas.12841. Epub 2015 Jul 22. Review.

PMID:
26200258
48.

The epigenetics of multiple sclerosis and other related disorders.

van den Elsen PJ, van Eggermond MC, Puentes F, van der Valk P, Baker D, Amor S.

Mult Scler Relat Disord. 2014 Mar;3(2):163-75. doi: 10.1016/j.msard.2013.08.007. Epub 2013 Sep 26. Review.

PMID:
25878004
49.

Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis.

Klaver R, Popescu V, Voorn P, Galis-de Graaf Y, van der Valk P, de Vries HE, Schenk GJ, Geurts JJ.

J Neuropathol Exp Neurol. 2015 May;74(5):453-8. doi: 10.1097/NEN.0000000000000189.

PMID:
25853695
50.

Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.

Haarmann A, Nowak E, Deiß A, van der Pol S, Monoranu CM, Kooij G, Müller N, van der Valk P, Stoll G, de Vries HE, Berberich-Siebelt F, Buttmann M.

Acta Neuropathol. 2015 May;129(5):639-52. doi: 10.1007/s00401-015-1417-0. Epub 2015 Mar 27.

Supplemental Content

Loading ...
Support Center